IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2.

TitleIFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2.
Publication TypeJournal Article
Year of Publication2021
AuthorsLévy, R, Bastard, P, Lanternier, F, Lecuit, M, Zhang, S-Y, Casanova, J-L
JournalJ Clin Immunol
Volume41
Issue1
Pagination26-27
Date Published2021 01
ISSN1573-2592
KeywordsAdult, COVID-19, Female, Humans, Interferon Regulatory Factor-3, Interferon Type I, Interferon-alpha, Polyethylene Glycols, Primary Immunodeficiency Diseases, Recombinant Proteins, SARS-CoV-2, Toll-Like Receptor 3, Treatment Outcome
DOI10.1007/s10875-020-00933-0
Alternate JournalJ Clin Immunol
PubMed ID33392853
PubMed Central IDPMC7779095
Grant ListR01 AI088364 / AI / NIAID NIH HHS / United States
UL1 TR001866 / TR / NCATS NIH HHS / United States
U24 HG008956 / HG / NHGRI NIH HHS / United States
UM1 HG006504 / HG / NHGRI NIH HHS / United States